Advanced Search
Contact | Corporate | Help

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

Sponsors:
  • M.D. Anderson Cancer Center
  • Aventis Pharmaceuticals
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Head and Neck Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Docetaxel
  • Drug: OSI-774
  • Drug: Cisplatin
Enrollment:
50

Additional information about NCT00076310.


SourceSolution © 2008-2012